Kura Oncology
KURA
#6361
Rank
โ‚ฌ0.82 B
Marketcap
9,29ย โ‚ฌ
Share price
-2.66%
Change (1 day)
68.52%
Change (1 year)

Revenue for Kura Oncology (KURA)

Revenue in 2026 (TTM): โ‚ฌ61.18 Million

According to Kura Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ62.77 Million. In 2025 the company made a revenue of โ‚ฌ57.44 Million an increase over the revenue in the year 2024 that were of โ‚ฌ51.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kura Oncology from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ61.18 M6.52%
2025 โ‚ฌ57.44 M10.94%
2024 โ‚ฌ51.77 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA